Zobrazeno 1 - 10
of 17
pro vyhledávání: '"L. L. Gluud"'
Umbilical hernia repair in patients with cirrhosis: systematic review of mortality and complications
Autor:
C. Snitkjær, K. K. Jensen, N. A. Henriksen, M. P. Werge, N. Kimer, L. L. Gluud, M. W. Christoffersen
Publikováno v:
Hernia. 26:1435-1445
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::48ac1780a5433b2cd712ea7ecb2ab552
https://doi.org/10.1007/s10029-022-02598-7
https://doi.org/10.1007/s10029-022-02598-7
Publikováno v:
Alimentary pharmacologytherapeutics. 32(7)
Multiple randomized trials have been published on antiviral treatment for chronic hepatitis C.To meta-analyse the effect of adding ribavirin to interferon for chronic hepatitis C.The results of randomized trials were combined in cumulative meta-analy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::d3824f1005dbd8e393dde7ad51d6e09c
https://pubmed.ncbi.nlm.nih.gov/21569068
https://pubmed.ncbi.nlm.nih.gov/21569068
Publikováno v:
Alimentary pharmacologytherapeutics. 32(7)
The evidence concerning the use of isosorbide-mononitrate (IsMn) for oesophageal varices is equivocal.To assess the effects of IsMn for patients with oesophageal varices and no previous bleeding (primary prevention) or previous variceal bleeding (sec
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::1e89248a4d0e1776d3bbf529b46af3b0
https://pubmed.ncbi.nlm.nih.gov/20839387
https://pubmed.ncbi.nlm.nih.gov/20839387
Publikováno v:
Alimentary pharmacologytherapeutics. 32(3)
Several liver diseases have been associated with oxidative stress. Accordingly, antioxidants have been suggested as potential therapeutics for various liver diseases. The evidence supporting these suggestions is equivocal.To assess the benefits and h
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::d397fe4709f7adbda72ce498d497667c
https://pubmed.ncbi.nlm.nih.gov/20955448
https://pubmed.ncbi.nlm.nih.gov/20955448
Publikováno v:
Alimentary pharmacologytherapeutics. 27(9)
Tranexamic acid may reduce upper gastrointestinal bleeding and stabilize patients before endoscopic treatments.To review randomized trials on tranexamic acid for upper gastrointestinal bleeding.Manual and electronic searches of The Cochrane Library,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::e18b2cd7ea389d12b5054b4bef4baa12
https://pubmed.ncbi.nlm.nih.gov/18248659
https://pubmed.ncbi.nlm.nih.gov/18248659
Publikováno v:
The Cochrane database of systematic reviews. (2)
Hepatitis C is a major cause of liver-related morbidity and mortality. Ribavirin plus interferon combination therapy is presently considered the optimal treatment of interferon naive patients with chronic hepatitis C, but its role in relapsers and no
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::9415099c88e1b4d826b3017ea4b378bb
https://pubmed.ncbi.nlm.nih.gov/12076442
https://pubmed.ncbi.nlm.nih.gov/12076442
Publikováno v:
Alimentary pharmacologytherapeutics. 25(10)
About 170 million patients worldwide have chronic hepatitis C. Pegylated interferon plus ribavirin is currently the recommended therapy.To evaluate the beneficial and harmful effects of pegylated interferon plus ribavirin vs. interferon plus ribaviri
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::175dcc1e0397a292c47035180ab9ea25
https://pubmed.ncbi.nlm.nih.gov/17451561
https://pubmed.ncbi.nlm.nih.gov/17451561
Publikováno v:
The Cochrane database of systematic reviews. (4)
Hepatitis C is a major cause of liver-related morbidity and mortality. The disease progresses without symptoms for several decades. Ribavirin monotherapy may represent a treatment for some patients.To assess the beneficial and harmful effect of ribav
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::88af0cd69b2c8e69abff09a5d62ca5a9
https://pubmed.ncbi.nlm.nih.gov/19821346
https://pubmed.ncbi.nlm.nih.gov/19821346
Publikováno v:
The Cochrane database of systematic reviews. (3)
Hepatitis C is a major cause of liver-related morbidity and mortality. The disease progresses without symptoms for several decades and most patients are diagnosed based on the presence of hepatitis C virus ribonucleic acid and elevated transaminases.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::40cd3f2aa8370fdb63567fdf3913f471
https://pubmed.ncbi.nlm.nih.gov/20091577
https://pubmed.ncbi.nlm.nih.gov/20091577
Publikováno v:
The Cochrane database of systematic reviews. (4)
Hepatic encephalopathy may be associated with an impairment of the dopaminergic neurotransmission. Dopaminergic agonists may therefore have a beneficial effect on patients with hepatic encephalopathy.To evaluate the beneficial and harmful effects of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::6c65ae1d67d8d9fa42500055d261087b
https://pubmed.ncbi.nlm.nih.gov/24515383
https://pubmed.ncbi.nlm.nih.gov/24515383